Foresight Diagnostics

Foresight Diagnostics is a CLIA-certified, CAP-accredited cancer diagnostics company founded in 2020 in Boulder, Colorado by Stanford physicians and scientists, and since February 2026 a wholly owned subsidiary of Natera. Its Foresight CLARITY minimal residual disease (MRD) platform is a liquid-biopsy test powered by proprietary PhasED-Seq phased-variant sequencing and bioinformatics, detecting circulating tumor DNA at an analytical sensitivity below one part per million across lymphoma, lung and other solid tumors. The company sells laboratory testing services to biopharma sponsors, academic researchers and clinicians rather than software: it operates a central laboratory and publishes no public developer program, API, SDK or machine-readable specification of any kind.

Foresight Diagnostics is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Diagnostics, Oncology, and Genomics.

Foresight Diagnostics’ developer surface includes product news, support, and 12 more developer resources.

15.0/100 emerging Agent 3/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyHealthcareDiagnosticsOncologyGenomicsPrecision MedicineLaboratoryLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 15.0/100 · emerging
Contract Quality 0.0 / 21
Developer Ergonomics 0.7 / 17
Commercial Clarity 4.9 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 4.5 / 15
Agent readiness — 3/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 7 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/foresight-diagnostics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Pricing Plans 1

Published pricing tiers and plan structures.

Rate Limits 1

Documented rate limits and quota policies.

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Foresight Diagnostics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Design & Contract 1

Pagination, idempotency, versioning, errors, and events

Access & Security 2

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 4

The organization behind the API

Other 3

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: foresight-diagnostics
name: Foresight Diagnostics
description: 'Foresight Diagnostics is a CLIA-certified, CAP-accredited cancer diagnostics company founded in 2020 in Boulder,
  Colorado by Stanford physicians and scientists, and since February 2026 a wholly owned subsidiary of Natera. Its Foresight
  CLARITY minimal residual disease (MRD) platform is a liquid-biopsy test powered by proprietary PhasED-Seq phased-variant
  sequencing and bioinformatics, detecting circulating tumor DNA at an analytical sensitivity below one part per million across
  lymphoma, lung and other solid tumors. The company sells laboratory testing services to biopharma sponsors, academic researchers
  and clinicians rather than software: it operates a central laboratory and publishes no public developer program, API, SDK
  or machine-readable specification of any kind.'
image: https://foresight-dx.com/wp-content/uploads/2024/09/X-OpenGraph-Image-1200x630-2x.png
url: https://raw.githubusercontent.com/api-evangelist/foresight-diagnostics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pass
specificationVersion: '0.20'
created: '2026-08-16'
modified: '2026-08-16'
tags:
- Company
- Healthcare
- Diagnostics
- Oncology
- Genomics
- Precision Medicine
- Laboratory
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://foresight-dx.com/
- type: Products
  url: https://foresight-dx.com/foresight-products-services/
- type: Technology
  url: https://foresight-dx.com/our-technology/
- type: Resources
  url: https://foresight-dx.com/resources/
- type: News
  url: https://foresight-dx.com/news/
- type: BlogRSS
  url: https://foresight-dx.com/feed/
- type: Support
  url: https://foresight-dx.com/contact/
- type: TermsOfService
  url: https://foresight-dx.com/terms-of-use/
- type: PrivacyPolicy
  url: https://foresight-dx.com/privacy-policy/
- type: Careers
  url: https://foresight-dx.com/careers/
- type: Compliance
  url: conformance/foresight-diagnostics-conformance.yml
- type: Conformance
  url: conformance/foresight-diagnostics-conformance.yml
- type: DomainSecurity
  url: security/foresight-diagnostics-domain-security.yml
- type: LLMsTxt
  url: llms/foresight-diagnostics-llms.txt
x-enrichment:
  date: '2026-08-16'
  status: minimal
  artifacts_added: 6
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: 'Foresight Diagnostics is a CLIA-certified central laboratory that sells a liquid-biopsy MRD test, not software:
    its entire public presence is a 20-page WordPress marketing site whose only machine-readable endpoint is the stock WordPress
    wp-json CMS API, and no api./portal./developer./docs./app./results./ provider./status. subdomain of foresight-dx.com resolves
    in DNS.'
  evidence:
  - url: https://foresight-dx.com/openapi.json
    status: 404
  - url: https://foresight-dx.com/graphql
    status: 404
  - url: https://foresight-dx.com/.well-known/agent-card.json
    status: 404
  - url: https://foresight-dx.com/llms.txt
    status: 404
  - url: https://foresight-dx.com/page-sitemap1.xml
    status: 200
  checked: '2026-08-16'